08:02 AM EST, 01/15/2025 (MT Newswires) -- Keros Therapeutics ( KROS ) said Wednesday it has voluntarily halted all dosing in its phase 2 TROPOS trial for cibotercept in patients with pulmonary arterial hypertension due to new observations of pericardial effusion adverse events. The decision includes all treatment arms, including the 1.5 mg/kg and placebo groups. Keros Therapeutics ( KROS...

08:01 AM EST, 01/15/2025 (MT Newswires) -- The speech this Thursday on balance sheet normalization by Bank of Canada Deputy Governor Toni Gravelle has brought the discussion on quantitative tightening (QT) end timing and how the Bank of Canada will add replacement assets back to the forefront of market participants' minds, said RBC. The bank thinks the steady-state level of...

Jan 15 (Reuters) - Citigroup ( C/PN ) swung to a profit in the fourth quarter, fueled by strength in trading and a recovery in dealmaking that drove up investment banking fees. The third-largest U.S. lender reported a net income of $2.9 billion, or $1.34 per share, for the three months ended Dec. 31 on Wednesday. That compares with a...

BEIJING (Reuters) - China's commerce ministry said on Wednesday that it had added four U.S. companies to its so-called Unreliable Entity List for their involvement in arms sales to Taiwan, which China regards as part of its territory. The blacklisted companies, which include Pacific Rim Defense and Summit Technologies Inc., will be banned from exporting to and importing from China...